As of April 30, 2025, Viracta Therapeutics (VIRX) has a market cap of $655,779 Dollars USD. According to our data, Viracta Therapeutics is ranked No.9257 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 30, 2025 | $655,779 Dollars |
-89.69%
|
Dec 31, 2024 | $6.36 M |
-71.93%
|
Dec 29, 2023 | $22.65 M |
-60.96%
|
Dec 30, 2022 | $58.03 M |
-60.00%
|
Dec 31, 2021 | $0.15 B |
-47.73%
|
Dec 31, 2020 | $0.28 B |
-41.47%
|
Dec 31, 2019 | $0.47 B |
-19.05%
|
Dec 31, 2018 | $0.59 B |
-88.62%
|
Dec 29, 2017 | $5.15 B |
1.93%
|
Dec 30, 2016 | $5.05 B |
-32.96%
|
Dec 31, 2015 | $7.53 B |
-64.71%
|
Dec 31, 2014 | $21.34 B |
-46.20%
|
Dec 31, 2013 | $39.66 B |
12.86%
|
Dec 31, 2012 | $35.14 B |
258.97%
|
Dec 30, 2011 | $9.79 B |
-62.50%
|
Dec 31, 2010 | $26.11 B |
-51.40%
|
Dec 31, 2009 | $53.72 B |
234.37%
|
Dec 31, 2008 | $16.07 B |
-83.92%
|
Dec 31, 2007 | $99.90 B |
-55.97%
|
Dec 29, 2006 | $226.92 B |
-9.24%
|
Dec 30, 2005 | $250.01 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Kura Oncology
KURA
|
$0.53 B |
0.000 M
|
![]() USA
|
![]() Syndax Pharmaceuticals
SNDX
|
$1.18 B |
0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.88 B |
-0.000 M
|
![]() Canada
|
![]() Blueprint Medicines
BPMC
|
$5.71 B |
-0.000 M
|
![]() USA
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.17 B |
0.000 M
|
![]() USA
|
![]() MacroGenics
MGNX
|
$0.10 B |
-0.000 M
|
![]() USA
|
![]() TG Therapeutics
TGTX
|
$6.89 B |
0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$69.44 M |
0.000 M
|
![]() UK
|
![]() Allogene Therapeutics
ALLO
|
$0.33 B |
-0.000 M
|
![]() USA
|
Market Cap | = | VIRX Stock Price | * | VIRX Shares Outstanding |
= | $0.02 | * | 39.74 M | |
= | $655,779 Dollars |